SECsense Logo

Omega Therapeutics, Inc. 8-K Filing: Key Updates You Need to Know

$OMGA
Form 8-K
Filed on: 2025-02-24
Source
Omega Therapeutics, Inc. 8-K Filing: Key Updates You Need to Know

Based on the provided XML section from a financial report, here are the key pieces of information extracted:

  1. Filing Type: The document is an 8-K filing, which is a report that public companies must file with the SEC to disclose major events that shareholders should know about.
  2. Company Information:
  • Name: Omega Therapeutics, Inc.
  • CIK (Central Index Key): 0001850838
  • SEC File Number: 001-40657
  • EIN (Employer Identification Number): 81-3247585
  • Address: 140 First Street, Suite 501, Cambridge, MA 02141
  • Contact Number: (617) 949-4360
  1. Stock Information:
  • Common Stock Par Value: $0.001 per share
  • Ticker Symbol: OMGA
  • Exchange: NASDAQ
  1. Report Date: The report covers a specific date, February 18, 2025, indicating that it likely details an event or update relevant to that specific date.
  2. Context Duration: The context of the report is set for a single day (February 18, 2025).

Insights:

  • The 8-K filing suggests that Omega Therapeutics, Inc. has an event or piece of information that is significant enough to warrant immediate disclosure to investors and the public. This could involve changes in management, financial results, or other material events.
  • The company's details such as its SEC identifiers and contact information are important for investors seeking to verify the legitimacy of the filing or wishing to reach out for further information.
  • As a publicly traded company on NASDAQ, Omega Therapeutics, Inc. is subject to regulatory scrutiny and must comply with SEC reporting requirements, which enhances transparency for investors.

    Overall, the extracted information indicates that the report is a formal disclosure related to Omega Therapeutics, which is essential for stakeholders to monitor the company's status and developments.